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This review evaluates evidence for a bidirectional relationship
between diabetes and periodontal diseases. A comprehensive
Medline search of the post-1960 English language literature was
employed to identify primary research reports of relationships
between diabetes and periodontal diseases. Reports included in
the review on the adverse effects of diabetes on periodontal
health (DM→PD) were restricted to those comparing periodon-
tal health in subjects with and without diabetes. Review of
adverse affects of periodontal infection on glycemic control
included reports of periodontal treatment studies and follow-up
observational studies in which changes in glycemic control could
be assessed. Observational studies reporting DM→PD provided
consistent evidence of greater prevalence, severity, extent, or pro-
gression of at least one manifestation of periodontal diseases in
the large majority of reports (supportive evidence in 44/48 total
reviewed; 37/41 cross-sectional and 7/7 cohort). Additionally,
there were no studies reviewed with superior design features to
refute this association. Treatment studies provided direct evi-
dence to support periodontal infection having an adverse, yet
modifiable, effect on glycemic control. However, not all inves-
tigations reported an improvement in glycemic control after
periodontal treatment. Additional evidence to support the effect
of severe periodontitis on increased risk for poorer glycemic
control comes from 2 follow-up observational studies. The evi-
dence reviewed supports viewing the relationship between dia-
betes and periodontal diseases as bidirectional. Further rigorous,
systematic study is warranted to establish that treating peri-
odontal infections can be influential in contributing to glycemic
control management and possibly to the reduction of the bur-
den of complications of diabetes mellitus. Ann Periodontol
2001;6:99-112.
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D
iabetes mellitus and chronic peri-
odontitis are common chronic dis-
eases in adults in the U.S. popu-
lation. Diabetes mellitus is disease of
metabolic dysregulation characterized by
hyperglycemia due to defects in insulin
secretion, insulin action, or both. Dys-
regulation of protein and lipid metabo-
lism also occurs. Particularly susceptible
individuals or those with chronic poor
metabolic control may experience one
or more commonly recognized compli-
cations in the eyes, heart, blood vessels,
kidney, and nervous system. These com-
plications are associated with a signifi-
cant burden for the individual and soci-
ety in terms of increased morbidity and
premature mortality. This increased bur-
den includes direct costs of medical care
and indirect costs such as lost produc-
tivity.1
There are 2 major types of overt dia-
betes in the U.S., Type 1 (formerly clas-
sified as insulin-dependent) and Type 2
(formerly classified as non-insulin-depen-
dent).2 Additional types of diabetes
include gestational diabetes mellitus,
which affects approximately 3% to 5% of
all pregnancies, and diabetes associated
with or secondary to other conditions,
comprising 1% to 2% of individuals with
diabetes in the U.S.1,2 Type 2 diabetes is
most prevalent; approximately 90% to
95% of people diagnosed with diabetes in
the U.S. have Type 2, and almost all
people ages 45 years and older diag-
nosed with diabetes have Type 2. Over
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the past 35 years, diabetes prevalence has increased
3-fold.3 Several factors associated with this increase
in prevalence include aging of the U.S. population,
reduction in mortality of persons with diabetes, changes
in criteria used to diagnose diabetes, and an increase
in the prevalence of risk factors for diabetes such as
obesity and physical inactivity.3
Prevalence of Type 2 diabetes is positively associ-
ated with age and minority status. Among people 65
years or older, diabetes prevalence is approximately
3.5 times greater than prevalence for people of all
ages.3 Several minority ethnic populations are 2 to 3
times more likely to have diabetes than non-Hispanic
white individuals of similar age in the U.S.4
The 2 most common periodontal diseases are gin-
givitis and chronic periodontitis. Gingivitis is preva-
lent, with approximately 50% of the U.S. population in
all age groups exhibiting reversible gingival inflam-
mation.5 Chronic periodontitis is a potentially pro-
gressive bacterial infection resulting in inflammation
and destruction of tooth-supporting tissues. However,
moderate or severe chronic periodontitis, with destruc-
tion of periodontal attachment tissues, is much less
common than gingivitis, affecting approximately 13%
of the entire U.S. population.6
The biologic mechanisms important in diabetes
adversely affecting periodontal health are likely to be
multifactorial. Mechanisms such as microangiopathy,
alterations in gingival crevicular fluid, alterations in col-
lagen metabolism, altered host inflammatory response,
altered subgingival microflora, and genetic predisposi-
tion have been proposed as contributory.7-12
The purpose of this report is to review the evidence
for a bidirectional, adverse interrelationship between
diabetes mellitus and periodontal diseases.
DIABETES: EFFECTS ON PERIODONTAL
HEALTH
Current evidence supporting the link between diabetes
mellitus and periodontal diseases comes from a review
of English language literature published since 1960.
This review was conducted using a Medline search, as
well as reviewing reference lists of relevant papers
obtained from the search to identify primary research
reports on investigations of relationships between dia-
betes and periodontal diseases. The reports with infor-
mation on the effects of diabetes on periodontal health
included in the review were restricted to those that
compared periodontal health in subjects with and with-
out diabetes.
To summarize the evidence on the effects of diabetes
on periodontal health, studies were broadly classified
by age group and type of diabetes (Table 1). Using this
classification scheme, there were 10 reports focusing
principally on children and adolescents with Type 1
diabetes;13-22 all except 113 reported greater preva-
lence, extent, or severity of at least one measure of
periodontal disease. Another set of studies of subjects
between the ages of 15 and 35 years with Type 1 dia-
betes all reported greater prevalence, extent, or sever-
ity of at least one measure or index of periodontal dis-
ease.23-28 A third set of studies of Type 1 diabetes (or
with subjects reported as being insulin-dependent with-
out actual diabetes type specified) included adults
between 20 and 70 years old.29-33 All 5 of these reports
also noted greater prevalence, extent, or severity of at
least one measure or index of periodontal disease.
There are a smaller number of studies on the rela-
tionship between Type 2 diabetes and periodontitis.
The review identified 8 reports limited to subjects with
Type 2 diabetes. Three of the reports34-36 included
only adults. The remaining 5 reports are from an epi-
demiologic study in the Pima Indians of the Gila River
Indian Community, Arizona and include subjects ages
5 and older37 or 15 and older.38-41 These 8 studies all
reported significantly poorer periodontal health in sub-
jects with diabetes. A subset of these reports provided
additional epidemiologic parameter estimates of asso-
ciation and risk. Emrich et al.39 reported that the odds
were approximately 3 times greater for people with
diabetes to have destructive periodontal disease after
controlling for other important factors. Nelson et al.38
found a 2.6-fold greater risk of advanced periodontal
disease incidence, and Taylor et al.41 reported that
subjects with Type 2 diabetes had a 4-fold greater risk
for more severe alveolar bone loss progression.
Several reports consist of analyses in which sub-
jects with Type 1 and Type 2 diabetes were not dis-
tinguished. All of the studies in this subset were cross-
sectional and included adult subjects, although 2
studies in this group included children or adolescents
as well.42,43 Eight of these 10 studies reported greater
prevalence, extent, or severity of periodontal disease
for at least one measure or index of periodontal dis-
ease.42,44-50 Hove and Stallard51 and Benveniste et
al.43 did not find significant differences in periodontal
disease between subjects with and without diabetes.
Finally, there is a set of cross-sectional studies in
which the type of diabetes was not specified and was
not easily determined from other information provided.
Five of the 8 reports in this set included only
adults.27,52-55 The other 3 reports included subjects
with ages ranging from childhood to older adult-
hood.56-58 All of these studies found subjects with dia-
betes to have increased prevalence, extent, or sever-
ity of periodontal disease. Two of the population-based
surveys, Grossi et al.53 and Dolan et al.,55 provide epi-
demiologic estimates of association for diabetes and
attachment loss severity, with diabetic individuals being
approximately twice as likely to have more severe
attachment loss than those without diabetes, after con-




* Diabetes type: 1 = Type 1 diabetes mellitus; 2 = Type 2 diabetes mellitus; 1,2 = subjects with both Type 1 and Type 2 diabetes mellitus included; 9 = diabetes
type not specified and not clearly ascertainable from other information in the report.
† Ages: subjects’ ages presented as minimum, maximum reported for those with diabetes (a) and controls (b) unless otherwise specified.
‡ Measure of periodontal disease status. Measures used include: Ging = gingivitis or gingival bleeding; Pd = probing depth; Lpa = loss of periodontal attachment;
XRBL = radiographic bone loss; JPS = juvenile periodontal score; MGI = modified gingival index; PI = Russell’s periodontal index; PDR = periodontal disease rate
(proportion of teeth affected by periodontal disease). The number following the measure corresponds to greater disease in those with diabetes (1) or no
difference between those with diabetes and controls (0). The letters following the number correspond to the parameter(s) assessed in the study: e = extent; i =
incidence; p = prevalence; s = severity; r = progression.
§ Hierarchy of evidence based on classification scheme used by U.S. Preventive Services Task Force99: I = evidence obtained from at least one properly
randomized controlled trial; II-1 = evidence obtained from well-designed controlled trial without randomization; II-2 = evidence obtained from well-designed
cohort or case-control analytic studies, preferably from more than one center or research group; II-3 = evidence obtained from multiple time series with or
without the intervention; dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be
regarded as this type of evidence; III = opinions of respected authorities, based on clinical experience; descriptive studies and case reports; or reports of expert
committees.
  Diabetes type not specified but ascertained by reviewer from other information in the report.
Table 1.
Summary of Studies on the Association Between Diabetes and Periodontal Diseases,
Classified by Strength of Evidence, Diabetes Type, and Age
Periodontal Other
N Subjects Ages† Measure: Diabetes-Related
Study Diabetes a. Diabetics a. Diabetics Diabetes Variables Evidence
Reference Country Design Type* b. Controls b. Controls Effect‡ Considered Level§
Firatli, 199716 Turkey Prospective 1 a. 44 a. 12.2 (mean) Ging: 0s Glycemic control II-2
b. 20 b. 12.3 (mean) Pd: 0s Duration of
Lpa: 1s diabetes
Cohen et al., USA Prospective 1 a. 21 a. 18, 35 Ging: 1s None II-2
197023 b. 18 b. 18, 35 Lpa: 1r, 1s
Tervonen and Finland Prospective 1 a. 36 a. 24, 36 Ging: 0e Glycemic control II-2




Novaes et al., Brazil Prospective 2 a. 30 a. 30, 77 Pd: 1s, 1r Glycemic control II-2
199634 b. 30 b. 30, 67 Lpa: 1s, 1r
Nelson et al., USA Prospective 2 a. 720 a. 15, 55+ XRBL: 1i, 1p None II-2
199038 b. 1,553 b. 15, 55+
Taylor et al., USA Prospective 2 a. 24 a. 15, 57 XRBL: 1i, 1r None II-2
199841 b. 338 b. 15, 57
Taylor et al., USA Prospective 2 a. 21 a. 15, 49 XRBL: 1i, 1r Glycemic control II-2
199840 b. 338 b. 15, 49
Goteiner et al., USA Cross- 1 a. 169 a. School ages Ging: 0s None III
198613 sectional b. 80 b. 5, 18 Lpa: 0p, 0s
PDI: 0s
Harrison and USA Cross- 1 a. 30 a. 4, 19 Ging: 1s Glycemic control III
Bowen, 198714 sectional b. 30 b. 4, 19 Lpa: 1p
Novaes et al., Brazil Cross- 1 a. 30 a. 5, 18 Ging: 1s None III
199122 sectional b. 30 b. 5, 18 Pd: 0s
XRBL: 1s
Cianciola et al., USA Cross- 1 a. 263 a. <10, >19 Ging: 1p Duration of III
198218 sectional b. 208 b. <10, >19 Lpa: 1p diabetes
XRBL: 1p, 1s
JPS: 1p,1s
de Pommereau France Cross- 1 a. 85 a. 12, 18 Ging: le Glycemic control III
et al., 199215 sectional b. 38 b. 12, 18 Lpa: 0e, 0p, 0s Duration of
XRBL: 0e, 0p, 0s diabetes
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Table 1. (continued)
Summary of Studies on the Association Between Diabetes and Periodontal Diseases,
Classified by Strength of Evidence, Diabetes Type, and Age
Periodontal Other
N Subjects Ages† Measure: Diabetes-Related
Study Diabetes a. Diabetics a. Diabetics Diabetes Variables Evidence
Reference Country Design Type* b. Controls b. Controls Effect‡ Considered Level§
Ringelberg et al., USA Cross- 1 a. 56 a. 10, 16 Ging: 1s None III
197719 sectional b. 41 b. 10, 12 MGI: 1s
Firatli et al., Turkey Cross- 1 a. 77 a. 12.5 (mean) Ging: 0s Duration of III
199620 sectional b. 77 b. 12.6 (mean) Pd: 1s diabetes
Lpa: 1s
Pinson et al., USA Cross- 1 a. 26 a. 7-18 Ging: 1s Glycemic control III
199517 sectional b. 24 b. 7-18 Pd: 0s Duration of
Lpa: 0s diabetes
Faulconbridge England Cross- 1 a. 94 a. 5, 17 Ging: 1s Duration of III
et al., 198121 sectional b. 94 b. 5, 17 diabetes
Kjellman et al., Sweden Cross- 1 a. 105 a. 15, 24 Ging: 1e Glycemic control III
197025 sectional b. 52 b. 15, 24 Pd: 0s Diabetes
XRBL: 0s complications
Güven et al., Turkey Cross- 1 a. 10 a. 18, 27 Ging: 1e None III
199624 sectional b. 52 b. 19, 22
Rylander et al., Sweden Cross- 1 a. 46 a. 18, 26 Ging: 1e, 1p Diabetes III
198726 sectional b. 41 b. 19, 25 Pd: 0e complications
Lpa: 1e, 1p
XRBL: 0p
Sznajder et al., Argentina Cross- 1 a. 20 a. 9, 29 Ging: 1s None III
197827 sectional b. 26 b. 9, 29 Lpa: 0s
Galea et al., Malta Cross- 1 a. 82 a. 5, 29 Pd: 1p Glycemic control III




Hugoson et al., Sweden Cross- 1 a. 154 a. 20, 70 Ging: 1e Duration of III
198930 sectional b. 77 b. 20, 70 Pd: 1e, 1p, 1s diabetes
XRBL: 1s
Glavind et al., Denmark Cross- 1 a. 51 a. 20, 40 Ging: 0s Duration of III
196829 sectional b. 51 b. 20, 40 Pd: 0s diabetes
Lpa: 1s Diabetes
XRBL: 1s complications
Thorstensson Sweden Cross- 1 a. 117 a. 40, 70 Ging: 0e Duration of III
and Hugoson, sectional b. 99 b. 40, 70 Pd: 1e, 1s diabetes
199331 XRBL: 1s Onset age
Tervonen et al., Finland Cross- 1 a. 35 a. 29.7 (mean) XRBL: 1e Glycemic control III








Summary of Studies on the Association Between Diabetes and Periodontal Diseases,
Classified by Strength of Evidence, Diabetes Type, and Age
Periodontal Other
N Subjects Ages† Measure: Diabetes-Related
Study Diabetes a. Diabetics a. Diabetics Diabetes Variables Evidence
Reference Country Design Type* b. Controls b. Controls Effect‡ Considered Level§
Morton et al., Mauritius Cross- 2 a. 24 a. 26, 76 Ging: 1p None III
199535 sectional b. 24 b. 25, 73 Pd: 1s
Lpa: 1s
Shlossman et al., USA Cross- 2 a. 736 a. 5, 45+ Lpa: 1p None III
199037 sectional b. 2,483 b. 5, 45+ XRBL: 1p
Emrich et al., USA Cross- 2 a. 254 a. 15, 55+ Lpa: 1p, 1s None III
199139 sectional b. 1,088 b. 15, 55+ XRBL: 1p, 1s
Sandberg et al., Sweden Cross- 2 a. 102 a. 64.8 (mean) Ging: 1e Glycemic control III
200036 sectional b. 102 b. 64.9 (mean) Pd: 1e Duration of
XRBL: 1p diabetes
Wolf, 197742 Finland Cross- 1,2 a. 186 a. 16, 60 Ging: 1s Glycemic control III




Benveniste et al., USA Cross- 1,2 a. 53 a. 5, 72 Ging: 0s None III
196743 sectional b. 71 b. 5, 72 Pd: 0p, 0s
Finestone and USA Cross- 1,2 a. 189 a. 20, 79 PI: 1s Glycemic control III




Belting et al., USA Cross- 1,2 a. 78 a. 20, 79 PI: 1s Diabetes severity III
196448 sectional b. 79 b. 20, 79
Oliver and USA Cross- 1,2 a. 114 a. 20, 64 Pd: 1e, 1p None III
Tervonen, 199345 sectional b. 15,132 b. 20, 64 Lpa: 1e, 0p, 0s
Yavuzyilmaz et al., Turkey Cross- 1,2 a. 17 a. 25, 74 Pd: 1s None III
199649 sectional b. 17 b. 19, 29
Bridges et al., USA Cross- 1,2 a. 118 a. 24, 78 Ging: 0s Glycemic control III
199646 sectional b. 115 b. 24, 78 Pd: 0s Duration of
Lpa: 1s diabetes
Sandler and Stahl, USA Cross- 1,2 a. 100 a. 20, 69 PDR: 1e None III
196050 sectional b. 3,894 b. 20, 69
Bacic et al., Yugoslavia Cross- 1,2 a. 222 a. <20, 60+ Pd: 1e, 1p, 1s Glycemic control III




Hove and Stallard, USA Cross- 1,2 a. 28 a. 20, 40+ Ging: 0s Duration of III
197051 sectional b. 16 b. 20, 40+ Pd: 0s diabetes
XRBL: 0s Diabetes severity
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As with other complications of diabetes, current
evidence also supports poorer glycemic control con-
tributing to poorer periodontal health. Primary
research reports in the literature investigating rela-
tionships between glycemic control level and peri-
odontal disease have been predominantly studies
where subjects either had Type 1 diabetes, a com-
bination of both Type 1 and Type 2 diabetes, or
where the diabetes type was not specified (Table 2).
There have been only 5 reports published on the
association between glycemic control and periodon-
tal disease specifically in Type 2 diabetes.34,36,40,59,60
Four of these studies found poorer glycemic control
to be a significant factor associated with poorer peri-
odontal health.34,40,59,60 Among the studies provid-
ing information on differences in periodontal health
classified by glycemic control status, most have been
cross-sectional, with 19/34 reporting more frequent
or severe periodontal disease in those with poorer
glycemic control14,16,25,28,32-34,40,44,45,54,59-66 and 15
reporting no differences.15,17,26,36,42,46,47,51,57,67-72
Among the follow-up studies in this body of litera-
ture, 8/9 reported poorer periodontal health in sub-
jects with poorer glycemic control.16,32,34,40,60,63,64,66
Additionally, among reports published before 1990,
6/16 reported more frequent or severe periodontal
disease in subjects with poorer glycemic con-
trol,14,25,28,44,54,61 whereas 13/18 papers published
since 1990 reported results supporting poorer glycemic
control associated with or contributing to more severe
or frequent periodontal disease.16,32-34,40,45,59,60,62-66
Although the preponderance of studies included in
this review of the adverse effects of diabetes on peri-
odontal health are cross-sectional and describe find-
ings of convenience samples, principally from outpa-
tients in hospitals and clinics, the smaller subset of
longitudinal and population-based studies also strongly
supports the association between diabetes and
increased occurrence and severity of periodontal dis-
eases. While limitations on causal inference must be
considered, the literature provides consistent evidence
of greater prevalence, severity, or extent of at least
Table 1. (continued)
Summary of Studies on the Association Between Diabetes and Periodontal Diseases,
Classified by Strength of Evidence, Diabetes Type, and Age
Periodontal Other
N Subjects Ages† Measure: Diabetes-Related
Study Diabetes a. Diabetics a. Diabetics Diabetes Variables Evidence
Reference Country Design Type* b. Controls b. Controls Effect‡ Considered Level§
Mackenzie and USA Cross- 9 a. 124 a. 32, 78 XRBL: 0s None III
Millard, 196352 sectional b. 92 b. 32, 78
Sznajder et al., Argentina Cross- 9 a. 63 a. 30, 49 Ging: 1s None III
197827 sectional b. 39 b. 30, 50 Lpa: 1s
Dolan et al., USA Cross- 9 Weighted a. 45, 75+ Lpa: 1e, 1p, 1s None III
199755 sectional a. 107 b. 45, 75+
b. 554
Grossi et al., USA Cross- 9 a. 1,426 All: 25, 74; Lpa: 1s, 1p None III
199453 sectional b. 69 unknown for
diabetics
Tervonen Finland Cross- 9 a. 50 a. <30, 40+ Ging: 1e Glycemic control III
and Knuuttila, sectional b. 53 b. <30, 40+ Pd: 1e, 1p
198654 XRBL: 0s
Campbell, 197256 Australia Cross- 9 a. 70 a. 17, 39 PI: 1p, 1s None III
sectional b. 102 b. 17, 39
Albrecht et al., Hungary Cross- 9 a. 1,360 a. 15, 65+ Ging: 1s None III
198857 sectional b. 625 b. 15, 65+ PI: 0s
Szpunar et al., 198958 USA Cross- 9 a. 474 a. 6, 65+ PI: 1s None III
(NHANES I) sectional b. 15,174 b. 6, 65+
Szpunar et al., 198958 USA Cross- 9 a. 322 a. 15, 65+ PI: 1s None III




Summary of Reports With Information on Effects of Glycemic Control on Periodontal Status,
Sorted by Strength of Evidence, Diabetes Type, and Age
Non-DM
Study Diabetes Comparison Evidence
Reference Country Design Type* Age Effect† Group‡ Level§
Seppälä, Seppälä,Ainamo, 199363 Finland Prospective 1 Adults 1 N II-2
Tervonen and Karjalainen, 199732 Finland Prospective 1 Adults 1 Y II-2
Karjalainen and Knuuttila, 199666 Finland Prospective 1 Children 1 N II-2
Firatli, 199716 Turkey Prospective 1 Children 1 Y II-2
Seppälä and Ainamo, 199464 Finland Prospective 1, 2 Adults 1 N II-2
Wolf, 197742 Finland Prospective 1, 2 Mixed ages 0 Y II-2
Novaes et al., 199634 Brazil Prospective 2 Adults 1 Y II-2
Taylor et al., 199840 USA Prospective 2 Mixed ages 1 Y II-2
Sastrowijoto et al., 198971 Netherlands Cross-sectional 1 Adults 0 N III
Moore et al., 199972 USA Cross-sectional 1 Adults 0 N III
Tervonen et al., 200033 Finland Cross-sectional 1 Adults 1 Y III
Gusberti et al., 198361 USA Cross-sectional 1 Children 1 N III
Barnett et al., 198468 USA Cross-sectional 1 Children 0 N III
Harrison and Bowen, 198714 USA Cross-sectional 1 Children 1 Y III
Sandholm et al., 198970 Finland Cross-sectional 1 Children 0 Y III
de Pommereau et al., 199215 France Cross-sectional 1 Children 0 Y III
Pinson et al., 199517 USA Cross-sectional 1 Children 0 Y III
Galea et al., 198628 Malta Cross-sectional 1 Children and 1 Y III
young adults
Kjellman et al., 197025 Sweden Cross-sectional 1 Children and 1 Y III
young adults
Rylander et al., 198726 Sweden Cross-sectional 1 Mixed ages 0 Y III
Safkan-Seppälä and Ainamo, 199262 Finland Cross-sectional 1 Mixed ages 1 N III
Finestone and Boorujy, 196744 USA Cross-sectional 1, 2 Adults 1 Y III
Bacic et al., 198847 Yugoslavia Cross-sectional 1, 2 Adults 0 Y III
Oliver and Tervonen, 199345 USA Cross-sectional 1, 2 Adults 1 N III
Tervonen and Oliver, 199365 USA Cross-sectional 1, 2 Adults 1 N III
* Diabetes type: 1 = Type 1 diabetes mellitus; 2 = Type 2 diabetes mellitus; 1,2 = subjects with both Type 1 and Type 2 diabetes mellitus included; 9 = diabetes
type not specified and not clearly ascertainable from other information in the report.
† 1 = Subjects with poorer glycemic control had poorer health than the comparison group(s); 0 = no difference in the periodontal health status between subjects
with poorer glycemic control and comparison group(s).
‡ Y = the report included subjects without diabetes as well as subjects with diabetes classified by glycemic control status.
§ Hierarchy of evidence based on classification scheme used by U.S. Preventive Services Task Force.99 I = evidence obtained from at least one properly
randomized controlled trial; II-1 = evidence obtained from well-designed controlled trial without randomization; II-2 = evidence obtained from well-designed
cohort or case-control analytic studies, preferably from more than one center or research group; II-3 = evidence obtained from multiple time series with or
without the intervention; dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be
regarded as this type of evidence; III = opinions of respected authorities, based on clinical experience; descriptive studies and case reports; or reports of expert
committees.
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Table 2. (continued)
Summary of Reports With Information on Effects of Glycemic Control on Periodontal Status,
Sorted by Strength of Evidence, Diabetes Type, and Age
Non-DM
Study Diabetes Comparison Evidence
Reference Country Design Type* Age Effect† Group‡ Level§
Bridges et al., 199646 USA Cross-sectional 1, 2 Adults 0 Y III
Ainamo et al., 1990 60 Finland Prospective 2 Adults 1 N III
(case report)
Unal et al., 199359 Turkey Cross-sectional 2 Adults 1 Y III
Sandberg et al., 200036 Sweden Cross-sectional 2 Adults 0 Y III
Hove and Stallard, 197051 USA Cross-sectional 9 Adults 0 Y III
Nichols et al., 197867 USA Cross-sectional 9 Adults 0 N III
Tervonen and Knuuttila, 198654 Finland Cross-sectional 9 Adults 1 Y III
Albrecht et al., 198857 Hungary Cross-sectional 9 Mixed ages 0 Y III
Hayden and Buckley, 198969 Ireland Cross-sectional 9 Mixed ages 0 N III
one manifestation of periodontal disease in the large
majority of studies. Additionally, there are no studies
reported in the literature with superior design features
to refute this assessment. The studies were conducted
in distinctly different settings with subjects from dif-
ferent ethnic populations, different age mixes, and with
a variety of measures of periodontal status (i.e., gin-
gival inflammation, pathologic probing depth, loss of
periodontal attachment, or radiographic evidence of
alveolar bone loss). The studies also used various pa-
rameters to summarize periodontal disease occurrence
(prevalence, incidence, extent, severity, or progres-
sion). Hence, this inevitable variation in methodology
and study populations limits the possibility that the
same biases or confounding factors apply in all the
studies and provides support for concluding that dia-
betes is a risk factor for periodontal disease incidence,
progression, and severity. Further, there is substantial
evidence to support a “dose-response;” i.e., as
glycemic control worsens, the adverse effects of dia-
betes on periodontal health become greater.
PERIODONTAL INFECTION: EFFECTS ON
GLYCEMIC CONTROL
While there is substantial evidence to support consid-
ering diabetes as a risk factor for poor periodontal
health, there is also evidence for periodontal infection
adversely affecting glycemic control in diabetes,
although this has been less extensively studied. Indi-
rect evidence comes from investigations of relation-
ships between insulin resistance and active inflamma-
tory connective tissue diseases,73,74 other clinical
diseases,73-76 and acute infection.77,78 Due to the high
vascularity of the inflamed periodontium, this inflamed
tissue may serve as an endocrine-like source for tumor
necrosis factor-α (TNF-α) and other inflammatory
mediators.12,79 Because of the predominance of Gram-
negative anaerobic bacteria in periodontal infection,
the ulcerated pocket epithelium could constitute a
chronic source of systemic challenge for bacterial prod-
ucts and locally produced inflammatory mediators.
TNF-α, interleukin (IL)-6, and IL-1, all mediators
important in periodontal inflammation, have been
shown to have important effects on glucose and lipid
metabolism, particularly following an acute infectious
challenge or trauma.12,80,81 TNF-α has been reported
to interfere with lipid metabolism and to be an insulin
antagonist.82,83 IL-6 and IL-1 have also been reported
to antagonize insulin action.81,84,85 To date, all reports
on an infection-related alteration of the endocrinologic-
metabolic status of the host have been with acute infec-
tions. There is a compelling need to evaluate these
relationships in the chronic infection context applica-
ble to periodontal infection.
More direct evidence regarding the effects of peri-
odontal infection on glycemic control in diabetes comes
from treatment studies42,63,64,86-93 and observational
studies94,95 (Table 3). There is evidence to support
periodontal infection/severe periodontitis having an
adverse, yet modifiable, effect on glycemic con-
trol.42,63,87,88,92 However, not all investigations report
an improvement in glycemic control after periodontal
treatment.64,89-91,93 There are major variations in the






















Effects of Periodontal Disease and Its Treatment on Glycemic Control: Clinical and Epidemiological Evidence
N Subjects
Study Diabetes a. Treatment (ages) Metabolic Control Evidence 
Reference Design Type b. Control (ages) Follow-Up Periodontal Therapy Outcome Measure Effects on Metabolic Control Level*
Aldridge et al., RCT 1 a. 16 (16-40) 2 months Treatment group: OHI, scaling, adjustment of Glycated hemoglobin, Periodontal treatment had no effect on I
Study 1, 199589 b. 15 (16-40) restoration margins, and reinforcement fructosamine change in glycated hemoglobin.
after 1 month. Control group: no 
treatment.
Aldridge et al., RCT 1 a. 12 (20-60) 2 months Treatment group: OHI, scaling and root Glycated hemoglobin Periodontal treatment had no effect on 1
Study 2, 199589 b. 10 (20-60) planing, extractions, root canal therapy. change in glycated hemoglobin.
Control group: no treatment.
Grossi et al., RCT 2 a. 89 (25-65) 12 months Treatment groups received systemic Glycated hemoglobin The 3 groups receiving doxycycline and I
1996,86 199792 b. 24 (25-65) doxycycline or placebo and ultrasonic ultrasonic bacterial curettage showed 
bactericidal curettage with irrigation using significant reductions (P ≤0.04) in mean 
either H2O, chlorhexidine, or povidone- glycated hemoglobin at 3 months.
iodine. Controls received ultrasonic bacterial
currettage with H2O irrigation and placebo
Smith et al., Treatment study, 1 a. 18 (26-57) 2 months Scaling and root planing with ultrasonics and Glycated hemoglobin No statistically or clinically significant change II-1
199690 non-RCT b. 0 curets, OHI. in glycated hemoglobin.
Westfelt et al., Treatment study, 1 a. 20 (45-65) 5 years Baseline oral hygiene instruction, scaling and Glycated hemoglobin The mean value of HbA1c between BL-24 II-1
199691 non-RCT and b. 20 (45-65) root planing followed by periodic prophys, months was not significantly different from 
2 OHI, localized subgingival plaque removal, that between 24-60 months.
and surgery at sites with bleeding on 
probing and PD >5 mm.
Christgau et al., Treatment study, 1 a. 20 (30-66) 2 months Scaling and root planing, subgingival irrigation Glycated hemoglobin No effect on glycated hemoglobin. II-1
199893 non-RCT and b. 20 (30-66) with chlorhexidine, OHI, extractions.
2
Taylor et al., Historical 2 †49 (severe 2-4 years Not applicable Glycated hemoglobin Those with severe periodontitis were II-2
199694 prospective periodontitis) 6 times more likely to have poor 
cohort 56 (less severe glycemic control at follow-up.
periodontitis)
* Hierarchy of evidence based on classification scheme used by U.S. Preventive Services Task Force.99 I = evidence obtained from at least one properly randomized controlled trial; II-1 =
evidence obtained from well-designed controlled trial without randomization; II-2 = evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than
one center or research group; II-3 = evidence obtained from multiple time series with or without the intervention; dramatic results in uncontrolled experiments (such as the results of the
introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence; III = opinions of respected authorities, based on clinical experience; descriptive studies
and case reports; or reports of expert committees.
† No treatment or control groups.
‡ No subjects received treatment.
§ Not specified.














































































Effects of Periodontal Disease and Its Treatment on Glycemic Control: Clinical and Epidemiological Evidence
N Subjects
Study Diabetes a. Treatment (ages) Metabolic Control Evidence 
Reference Design Type b. Control (ages) Follow-Up Periodontal Therapy Outcome Measure Effects on Metabolic Control Level*
Collin et al., Retrospective 2 ‡25 with diabetes 2-3 years Not applicable Glycated hemoglobin HbA1c level significantly increased in those II-2
199895 cohort (58-76) with advanced periodontitis, but not in 
40 without those without 
diabetes (59-77)
Williams and Descriptive § a. 9 (20-32) 3-7 months Extractions, scaling and curettage, Insulin requirement; 7/9 subjects had “significant” reduction III
Mahan, clinical study b. 0 gingivectomy, systemic antibiotics diabetes control in insulin requirements
196087 (not operationally 
defined)
Wolf, 197742 Treatment study, 1 a. 117 (16-60) 8-12 months Scaling and home care instructions, Blood glucose; Compared 23 subjects with improved oral III
non-RCT and b. 0 periodontal surgery, extractions, 24-hour urinary infection with 23 who had no improvement 
2 endodontic treatment, restorations, denture glucose; insulin after treatment for oral infection and 
replacement or repair dose inflammation. Subjects with improved oral 
inflammation and infection tended to 
demonstrate diabetic control improvement 
(P <0.1). Discussion states “treatment  of
periodontal inflammation and periapical 
lesions...does little to improve the control 
of diabetes.”
Miller et al., Treatment study, 1 a. 10 (not given) 8 weeks Scaling and root planing, systemic Glycated hemoglobin, Found decrease in glycated hemoglobin and III
199288 non-RCT b. 0 doxycycline glycated albumin glycated albumin in patients with improve- 
ment in gingival inflammation (P <0.01);
patients with no improvement in gingival 
inflammation had either no change or 
increase in glycated hemoglobin post-
treatment.
Seppälä et al., Treatment study, 1 a. 38, 1 year ; 2 years Scaling and root planing, periodontal surgery, Medical history for Reported an improvement of the HBA1 III
1993,63 199464 non-RCT 22, 2 years extractions baseline control levels of the PIDD and CIDD subjects 
26 PIDD, 1 year status; glycosylated (P <0.068; t test).
(48 ± 6) hemoglobin A1 and 
12 CIDD, 1 year blood glucose for 
(43 ± 5) assessing response
16 PIDD, 2 years to treatment
6 CIDD, 2 years
b. 0
Ann Periodontol Taylor
described in recent detailed reviews.12,96 Perhaps most
notable are the identification of only 3 published con-
trolled clinical trials;86,89,92 with 1 trial specifically
designed for periodontal treatment in patients with
Type 2 diabetes,86,92 and potential limitations in length
of follow-up time to assess changes in glycated hemo-
globin in studies reporting no improvement of glycemic
control.
Despite the variation in the literature, there is a dis-
tinction in the effect of periodontal treatment on
glycemic control related to the mode of therapy.12
Studies involving mechanical periodontal treatment
alone64,89,90,91,93 reported improvement in periodon-
tal status only (i.e., no change in glycemic control),
while studies including systemic antibiotics accompa-
nying mechanical therapy reported an improvement
in both periodontal status and glycemic control.87,88,92
It has been hypothesized that these differential results
due to antibiotic use (especially doxycycline) may
involve several mechanisms, including an antimicro-
bial effect, modulation of host response, and possibly
inhibition of the non-enzymatic glycosylation process.
Additional evidence to support the effect of severe
periodontitis on increased risk for poorer glycemic con-
trol comes from 2 longitudinal observational studies.
In a longitudinal epidemiological study of the Pima
Indians in Arizona, Taylor et al.94 found that subjects
with Type 2 diabetes in good to moderate control and
with severe periodontitis at baseline were approxi-
mately 6 times more likely to have poor glycemic con-
trol at approximately 2-years follow-up than those with-
out severe periodontitis at baseline. In another
observational study of 25 adults with Type 2 diabetes,
aged 58 to 77 years, Collin et al.95 also reported an
association between advanced periodontal disease and
impaired metabolic control.
The clinical and epidemiological evidence reviewed
provides support for the concept that periodontal infec-
tion contributes to poorer glycemic control in people
with diabetes mellitus. However, further rigorous, con-
trolled trials in diverse populations are warranted to
firmly establish that treating periodontal infections can
be influential in contributing to glycemic control man-
agement and possibly to the reduction of the burden
of complications of diabetes mellitus.
CONCLUSION
The evidence supports viewing the relationship
between diabetes and periodontal diseases as bidirec-
tional; that is, diabetes is associated with increased
occurrence and progression of periodontitis, and peri-
odontal infection is associated with poorer glycemic
control in people with diabetes. While treating peri-
odontal infection in people with diabetes is clearly an
important component in maintaining oral health, it
may also have an important role in establishing and
maintaining glycemic control. Additional rigorous clin-
ical investigations in diverse populations are warranted
to support and extend existing evidence that treating
periodontal infections can be influential in contributing
to glycemic control management and possibly to the
reduction of the burden of complications of diabetes
mellitus.
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